LCID
Lucid Group, Inc.
LCID has the edge over THCH overall, supported by stronger fundamentals and stronger modeled upside.
THCH
TH International Limited
THCH has slightly lower modeled downside risk, despite its lower overall score.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
THCH Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Unavailable |
THCH's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
THCH PE Valuation
THCH has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
THCH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect THCH's earnings, revenue and profitability to hold roughly steady.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
THCH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$2.33 | -$0.70 |
| Q1 2026 | -$2.23 | -$0.73 |
| Q4 2025 | -$1.99 | -$0.08 |
| Q3 2025 | -$1.56 | +$1.19 |
| Q2 2025 | -$1.63 | +$1.47 |
| Q1 2025 | -$1.50 | +$2.51 |
| Q4 2024 | -$1.91 | +$2.62 |
| Q3 2024 | -$2.75 | +$2.00 |
THCH is still losing money, but far less than before: $2.33 per share over the past year, against $5.40 at its worst in mid-2023.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over THCH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
THCH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.9M | -22% |
| Q1 2026 | $38.3M | -15% |
| Q4 2025 | $45.7M | -8.5% |
| Q3 2025 | $53.7M | -0.4% |
| Q2 2025 | $52.4M | -4.9% |
| Q1 2025 | $45.1M | -9.5% |
| Q4 2024 | $49.9M | -15% |
| Q3 2024 | $54M | -17% |
THCH's revenue has slid since its 2023 peak: $41M last quarter, down 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -20% | -9.2 points |
| Q1 2026 | -26% | -2.2 points |
| Q4 2025 | -28% | +2.1 points |
| Q3 2025 | -15% | -4.6 points |
| Q2 2025 | -11% | +4 points |
| Q1 2025 | -24% | +13 points |
| Q4 2024 | -30% | +29 points |
| Q3 2024 | -11% | +23 points |
THCH has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
THCH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $5.1M | +$5.3M |
| Q1 2026 | -$3.5M | -$3.5M |
| Q4 2025 | -$11.3M | -$6.5M |
| Q3 2025 | -$257.1K | +$1.7M |
| Q2 2025 | -$176.3K | -104% |
| Q1 2025 | -$32.9K | +$4M |
| Q4 2024 | -$4.7M | +$51.2M |
| Q3 2024 | -$2M | +$2.6M |
THCH has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
THCH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -4.3K shares |
| 3 years | +6.7% | +2M shares |
| 5 years | +21% | +5.6M shares |
| Available history | +21% | +5.6M shares |
THCH has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
THCH hasn't bought back shares in the past year.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
THCH Net Leverage
THCH's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
THCH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.7 | Neutral |
| Stochastic | 33.1 | Neutral |
THCH's weekly RSI is 42 (neutral) and its Stochastic is 33 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
THCH PE vs Consumer Cyclical Sector
THCH has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
THCH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.17 | 6% above |
| 20 week MA | $1.40 | 11% below |
| 50 week MA | $1.79 | 31% below |
| 100 week MA | $2.32 | 47% below |
| 200 week MA | $6.07 | 80% below |
THCH has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
THCH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $49.1 | $48.9 | -0.4% |
| 2022 | $48.9 | $15.7 | -68% |
| 2023 | $15.7 | $8.75 | -44% |
| 2024 | $8.75 | $3.73 | -57% |
| 2025 | $3.73 | $2.19 | -41% |
| 2026 YTD | $2.19 | $1.24 | -43% |
THCH has the edge over LCID on returns for 2026, with the stronger performance.